Facebook Likes Pharma. Pharma Likes Facebook. So Why Doesn’t FDA Like “Likes”?
Much fanfare and "sky is falling" comments have been made by bloggers regarding FDA's recent warning letter to a dietary supplement maker that used...
More Biologic Rx’s Mean Less DTCA Spending, But Not More Internet Ad Spending
By now you should be familiar with charts like the following, which documents the decline in direct-to-consumer advertising (DTCA).
What are the causes of this...
We Do Hope Y’All Will Enter! Contests Guarantee ROI for Diabetes Drug Marketing
"Hey y'all, I'm Paula Deen and these are my sons Bobby and Jamie," says Paula Deen, Novo Nordisk's Victoza diabetes drug spokesperson, in a...
Pharma Advertising Sequestration! DTC & Physician Ad Spending Cut 20% Across the Board!
According to MM&M: "Ad pages in medical/surgical journals fell precipitously in 2012, with companies buying 16,100 fewer pages than they did in 2011 (a...
Pharma DTC Ad Spending Took a Nosedive in 2012!
According to data from cegedim Strategic Data (CSD), DTC spending decreased by 22% in 2012 compared to 2011 (see chart below and here):
(click for...
The Widening Patient-Physician Gap: How Can (Should?) Pharma Marketers Facilitate the Conversation Between Patients...
A conversation with Alan Topin, President of Topin & Associates, about what he has called the 'Doctor-Patient Disconnect' and the role of pharmaceutical marketers in overcoming that disconnect by facilitating the conversation. Topin will also be a member of a panel moderated by PharmaGuy at the Social Media for Pharma conference. The panel is titled 'Getting To The Heart Of What Patients And HCPs Really Want And Need To Win Trust And Help Bridge The Widening Gap Between Patient And Prescriber.'
Sydney Wolfe’s 7-Year Drug Rule/Itch: Don’t Prescribe or Imbibe Any New Drug for First...
At the recent Selling Sickness conference in Washington, DC. Sydney Wolfe, MD (Public Citizen), gave a rousing keynote presentation. As I reported last week,...
Selling Sickness: The War Against the Medical-Industrial Complex
I am a fish out of water here at the 2013 Selling Sickness conference in Washington, D.C. Although the theme of the conference --...
The First Ever “Dear Doctor” Letter Regarding a Mobile Medical App Recall
When I wrote the Pharma Marketing News article "Some Unregulated Physician Smartphone Apps May Be Buggy" back in January 2012, I reported that Pfizer...
Will Ethics Revive (Exhume?) the Drug Industry’s Reputation?
Jennifer Miller, a fellow at the Edmund J Safra Center for Ethics at Harvard University and president of Bioethics International, a non-profit that advises educational programs on ethical issues on medicine and healthcare, is trying to develop the industry equivalent of a 'Good Housekeeping Seal of Approval.' This article summarizes her ideas and presents opinions of several naysayers.
